Trilogy Capital Inc. Merck & Co., Inc. Transaction History

Trilogy Capital Inc.

  • $2.15 Billion
  • Q3 2025

A detailed history of Trilogy Capital Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Trilogy Capital Inc. holds 43,258 shares of MRK stock, worth $4.02 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
43,258
Previous 44,531 2.86%
Holding current value
$4.02 Million
Previous $3.53 Million 2.98%
% of portfolio
0.17%
Previous 0.17%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025
SELL
$77.6 - $87.37 $98,784 - $111,222
-1,273 Reduced 2.86%
43,258 $3.63 Million
Q2 2025

Jul 18, 2025
BUY
$73.47 - $87.12 $2.49 Million - $2.95 Million
33,904 Added 319.04%
44,531 $3.53 Million
Q1 2025

May 06, 2025
BUY
$83.01 - $101.02 $38,018 - $46,267
458 Added 4.5%
10,627 $953,000
Q4 2024

Jan 27, 2025
SELL
$96.31 - $114.76 $179,907 - $214,371
-1,868 Reduced 15.52%
10,169 $1.01 Million
Q3 2024

Oct 18, 2024
SELL
$111.15 - $128.97 $25,008 - $29,018
-225 Reduced 1.83%
12,037 $1.37 Million
Q2 2024

Jul 22, 2024
BUY
$123.8 - $132.96 $787,368 - $845,625
6,360 Added 107.76%
12,262 $1.52 Million
Q1 2024

Apr 17, 2024
BUY
$113.24 - $131.95 $352,402 - $410,628
3,112 Added 111.54%
5,902 $778,000
Q4 2023

Jan 11, 2024
BUY
$100.18 - $109.02 $43,778 - $47,641
437 Added 18.57%
2,790 $304,000
Q3 2023

Oct 16, 2023
SELL
$102.95 - $114.33 $101,508 - $112,729
-986 Reduced 29.53%
2,353 $242,000
Q2 2023

Jul 24, 2023
BUY
$108.61 - $118.38 $62,776 - $68,423
578 Added 20.93%
3,339 $385,000
Q1 2023

Apr 17, 2023
SELL
$102.94 - $114.86 $331,569 - $369,964
-3,221 Reduced 53.84%
2,761 $293,000
Q4 2022

Feb 09, 2023
BUY
$87.44 - $112.11 $204,084 - $261,664
2,334 Added 63.98%
5,982 $663,000
Q3 2022

Oct 21, 2022
BUY
$84.53 - $94.96 $13,102 - $14,718
155 Added 4.44%
3,648 $314,000
Q2 2022

Jul 20, 2022
BUY
$83.49 - $94.64 $23,794 - $26,972
285 Added 8.88%
3,493 $318,000
Q1 2022

Apr 08, 2022
BUY
$73.51 - $82.4 $235,820 - $264,339
3,208 New
3,208 $263,000
Q1 2019

Apr 17, 2019
SELL
$69.58 - $79.36 $689,329 - $786,219
-9,907 Closed
0 $0
Q4 2018

Jan 15, 2019
SELL
$65.24 - $75.71 $51,800 - $60,113
-794 Reduced 7.42%
9,907 $757,000
Q3 2018

Oct 31, 2018
SELL
$57.69 - $67.84 $74,477 - $87,581
-1,291 Reduced 10.77%
10,701 $759,000
Q2 2018

Aug 20, 2018
SELL
$50.83 - $59.72 $11,385 - $13,377
-224 Reduced 1.83%
11,992 $728,000
Q1 2018

May 24, 2018
BUY
$50.96 - $59.23 $622,527 - $723,553
12,216 New
12,216 $665,000

Others Institutions Holding MRK

# of Institutions
3,915
Shares Held
1.9B
Call Options Held
30.1M
Put Options Held
27.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Trilogy Capital Inc. Portfolio

Follow Trilogy Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trilogy Capital Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email